To evaluate medication adherence in patients with chronic uveitis using the MARS-5 scale and investigate barriers to adherence, emphasizing the importance of these barriers in treatment outcomes.
Key Findings:
Medication adherence was assessed using the MARS-5 scale, with higher scores indicating better adherence. Specific adherence rates should be included.
A questionnaire identified common barriers to adherence, including treatment beliefs, motivation, and medication costs.
Interpretation:
Understanding adherence levels and barriers is crucial for optimizing treatment strategies in chronic uveitis patients.
Limitations:
The study was conducted at a single center, which may limit generalizability. This limitation could affect the applicability of findings to broader populations.
The adherence barrier questionnaire was not psychometrically validated, which may impact the reliability of the identified barriers.
Conclusion:
Improving patient education and addressing barriers can enhance adherence and clinical outcomes in chronic uveitis management.
